DDD Partners LLC lessened its stake in shares of ARK Genomic Revolution ETF (BATS:ARKG – Free Report) by 1.7% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 161,728 shares of the company’s stock after selling 2,744 shares during the quarter. DDD Partners LLC’s holdings in ARK Genomic Revolution ETF were worth $5,306,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other hedge funds have also recently added to or reduced their stakes in the business. Operose Advisors LLC purchased a new stake in ARK Genomic Revolution ETF during the 3rd quarter worth approximately $25,000. Stephens Consulting LLC acquired a new position in ARK Genomic Revolution ETF during the 3rd quarter valued at approximately $28,000. Allworth Financial LP boosted its position in ARK Genomic Revolution ETF by 65.3% during the 3rd quarter. Allworth Financial LP now owns 1,425 shares of the company’s stock valued at $40,000 after purchasing an additional 563 shares during the period. High Net Worth Advisory Group LLC boosted its position in ARK Genomic Revolution ETF by 80.9% during the 1st quarter. High Net Worth Advisory Group LLC now owns 1,118 shares of the company’s stock valued at $51,000 after purchasing an additional 500 shares during the period. Finally, BKM Wealth Management LLC acquired a new position in ARK Genomic Revolution ETF during the 4th quarter valued at approximately $78,000.
ARK Genomic Revolution ETF Stock Up 2.4 %
BATS:ARKG opened at $28.56 on Thursday. The firm’s 50-day moving average is $29.86 and its 200 day moving average is $28.76.
About ARK Genomic Revolution ETF
The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.
See Also
- Five stocks we like better than ARK Genomic Revolution ETF
- Best Aerospace Stocks Investing
- Bitcoin Depot Falls Into Value Territory With Expansion Underway
- What Is Dividend Yield and How Do You Calculate It?
- 7 Stocks That Will Drive the Weight Loss Drugs Market
- 10 Best Airline Stocks to Buy
- Cintas or UniFirst: Investors Win Either Way
Want to see what other hedge funds are holding ARKG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ARK Genomic Revolution ETF (BATS:ARKG – Free Report).
Receive News & Ratings for ARK Genomic Revolution ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ARK Genomic Revolution ETF and related companies with MarketBeat.com's FREE daily email newsletter.
